International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding

Author(s): Letendre William R

Issue: Nov/Dec 1997 - Diverse Ambulatory Patients
View All Articles in Issue

Page(s): 399-403

FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding Page 1

FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding Page 2

FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding Page 3

FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding Page 4

FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding Page 5

Download in electronic PDF format for $75

Abstract: In this article, the author, past president of the American College of Apothecaries, current chair of the Academy of Pharmacy Practice Management Section of Nontraditional Practice for the American Pharmaceutical Association, and a director of the Texas Pharmacists Association, discusses regulatory issues. He defines compounding and gray areas, and describes court actions, legislative action, the continuing debate and the hope for legislative relief.

Related Keywords: Congress, Court, FDC, Federal, GMP, JCPP, Law, Legislatiion, NABP, Regulations, Regulatory

Related Categories: BUSINESS, LEGAL, FDA

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
FDA and the Practice of Pharmacy: Regulatory Aspects of Compounding Letendre William R	Nov/Dec 1997 Pg. 399-403
Regulatory and Operational Issues of Founding a Compounding Pharmacy Smith Lisa K	Nov/Dec 2002 Pg. 434-437
NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies Allen Loyd V Jr	Mar/Apr 1997 Pg. 75-77
Is Veterinary Compounding Illegal Under Federal Law? Gibbs Jeffrey N	Nov/Dec 2004 Pg. 449-450
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
Documentation: Records and Reports Akers Michael J	Sep/Oct 2017 Pg. 373-380
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Timko Robert J, Crooker Philip EM	Mar/Apr 2014 Pg. 101-111
PreScription: State or Federal Control of Pharmacy Practice Allen Loyd V Jr	May/Jun 2007 Pg. 178
PreScription: Compounding Pharmacy Issues for 2017 Allen Loyd V Jr	Jan/Feb 2017 Pg. 4
Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations McCrory Gary	Mar/Apr 2016 Pg. 95-96
Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr	Jan/Feb 2018 Pg. 7-16
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Miller David G	Nov/Dec 2012 Pg. 476-478
Survey of State Veterinary Compounding Laws and Regulations Goodrum Jennifer	May/Jun 2005 Pg. 209-211
Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Chan Debora Schotik	Mar/Apr 2001 Pg. 97-100
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Miller David G	Jul/Aug 2012 Pg. 300-302 View Sample
PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc Allen Loyd V Jr	Sep/Oct 2019 Pg. 356
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Miller David G	Nov/Dec 2011 Pg. 471-472 View Sample
Compounding Pharmacies: Before and After an Inspection Kulkarni Darshan, Ricketts Samantha	Sep/Oct 2013 Pg. 358-362
Applying Quality of Design Concepts to Pharmacy Compounding Timko Robert J	Nov/Dec 2015 Pg. 453-463
Return to Top